Key result
This review discusses the risks of thromboembolism associated with assisted reproduction and the role of antithrombotic therapy in reducing these events.
Why the study?
Does antithrombotic therapy reduce the risk of thromboembolism and implantation failure in couples undergoing assisted reproduction?
Does antithrombotic therapy reduce the risk of thromboembolism and implantation failure in couples undergoing assisted reproduction?
This review discusses the risks of thromboembolism in assisted reproduction and the role of antithrombotic therapy in mitigating these risks and improving implantation success.
No takes yet. Share an insight, caveat, or question.
Thromboembolism risk in assisted reproduction warrants clinical vigilance; leaves open antithrombotic therapy benefits pending prospective trials.
Shannon M. Bates (2014) conducted a review in Infertility requiring assisted reproductive technology. Antithrombotic therapy was evaluated. This review discusses the risks of thromboembolism associated with assisted reproduction and the role of antithrombotic therapy in reducing these events.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: